About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Iranian Foreign Ministry spokesman: Iran expresses support for Oman after “US officials” issued threats.

2026-05-28

Iranian Foreign Ministry spokesman: Iran expresses support for Oman after “US officials” issued threats.

Other News
2026-05-27

People familiar with the matter said ERDOGAN is seeking to arrange a meeting with TRUMP next month, possibly immediately before or after a Turkey v. United States World Cup match in Los Angeles. The potential meeting would be held less than two weeks

People familiar with the matter said ERDOGAN is seeking to arrange a meeting with TRUMP next month, possibly immediately before or after a Turkey v. United States World Cup match in Los Angeles. The potential meeting would be held less than two weeks before a NATO summit to be hosted by Ankara, and, the sources said, comes amid growing signs that Washington plans to pare back its role supporting the military alliance in Europe. The people added that, if a meeting with TRUMP is secured, the two leaders could discuss bilateral and regional ties and each country’s role in NATO’s future development ahead of the summit scheduled for July 7-8.
2026-05-28

On May 28, at its regular monthly press briefing the Ministry of Natural Resources released and explained the Guiding Opinions on Accelerating High-Quality Development of Marine Drugs and Functional Products. Wang Xiaoyang, deputy director of the Dep

On May 28, at its regular monthly press briefing the Ministry of Natural Resources released and explained the Guiding Opinions on Accelerating High-Quality Development of Marine Drugs and Functional Products. Wang Xiaoyang, deputy director of the Department of Consumer Goods Industry at the Ministry of Industry and Information Technology, said MIIT is expediting preparation of the "15th Five-Year Plan for Pharmaceutical Industry" and is arranging to accelerate the development of "innovative medicines", "inclusive medicines", "digital-intelligence medicines" and "open medicines". The plan will designate marine drugs and functional products as priority development areas and, through improving top-level design, will further clarify development direction, specify development tasks, and provide clear guidance for the industry's high-quality development.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.